Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1883175 | 0.89 | IGF1R (0.47) | IGF1RCHRM1 | |
| SCHEMBL1876987 | 0.84 | IGF1R (0.54) | IGF1R | |
| SCHEMBL12636517 | 0.84 | IGF1R (0.51) | IGF1R | |
| SCHEMBL1876001 | 0.83 | IGF1R (0.49) | IGF1R | |
| SCHEMBL1876890 | 0.83 | IGF1R (0.55) | IGF1R | |
| SCHEMBL4149811 | 0.82 | IGF1R (0.46) | IGF1R | |
| SCHEMBL1879532 | 0.82 | IGF1R (0.51) | IGF1R | |
| SCHEMBL4149813 | 0.81 | IGF1R (0.47) | IGF1R | |
| SCHEMBL1876995 | 0.81 | IGF1R (0.44) | IGF1R | |
| SCHEMBL1130586 | 0.80 | IGF1R (0.43) | IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1979339-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007083017-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2007-07-26 | — | — | WO | disclosed |